Breaking News, Financial News

Financial Report: PAREXEL

Clinical Research Services revenue up 11% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL
 
1Q Revenues: $573.7 million (+8%)

1Q Earnings: $37.1 million (+43%)

Comments: Clinical Research Services (CRS) revenues were $369.8 million in the quarter, up 11%. PAREXEL Consulting Services (PC) revenues were flat at $56.4 million. PAREXEL Informatics (PI) revenues were $65.5 million, up 10%. Backlog at the end of September was $4.9 billion, up 5%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters